Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

2,999 public trials 572 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Active, Not Recruiting

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

NCT05673083

Conditions
Behavior, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
  • Misson Cancer + Blood Des Moines, Iowa, United States
  • Hematology-Oncology Associates of Central New York East Syracuse, New York, United States
View Trial Details
Active, Not Recruiting

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

NCT04464200

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +41 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

NCT03314181

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Univ of Colorado Cancer Center /ID# 167331 Aurora, Colorado, United States
  • Moffitt Cancer Center /ID# 169614 Tampa, Florida, United States
  • Winship Cancer Institute of Emory University /ID# 165427 Atlanta, Georgia, United States
  • The University of Chicago Medical Center /ID# 165429 Chicago, Illinois, United States
View all 40 locations
View Trial Details
Active, Not Recruiting

A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets

NCT05308654

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Stanford University School of Med /ID# 242809 Stanford, California, United States
  • Sylvester Comprehensive Cancer Center /ID# 243417 Miami, Florida, United States
  • Tulane University School of Medicine /ID# 244854 New Orleans, Louisiana, United States
  • American Oncology Partners of Maryland /ID# 244858 Bethesda, Maryland, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan

NCT05286229

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • National Cancer Center Hospital East /ID# 240943 Kashiwa-shi, Chiba, Japan
  • Hokkaido University Hospital /ID# 242672 Sapporo, Hokkaido, Japan
  • Kanazawa University Hospital /ID# 240948 Kanazawa, Ishikawa-ken, Japan
  • Duplicate_Okayama Medical Center /ID# 240949 Okayama, Okayama-ken, Japan
View Trial Details
Active, Not Recruiting

Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)

NCT02899052

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham - Main /ID# 151405 Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences /ID# 151399 Little Rock, Arkansas, United States
  • Memorial Healthcare System /ID# 224862 Hollywood, Florida, United States
  • Winship Cancer Institute of Emory University /ID# 161710 Atlanta, Georgia, United States
View all 32 locations
View Trial Details

Related conditions